Parsons Presbyterian Manor: Psychotropic Drug Violations - KS
The June 2026 inspection of Parsons Presbyterian Manor produced four deficiency citations. One of them landed in a category that carries particular weight in nursing home oversight: freedom from abuse, neglect, and exploitation. The specific violation involved psychotropic medications, drugs that act on the brain and central nervous system, given in ways that inspectors concluded were unnecessary or that may have limited residents' ability to function.
That last phrase matters. A resident whose movement, alertness, or behavior is chemically suppressed by a drug they don't need is, in the language federal regulators use, being chemically restrained. The inspection report places this finding under that framework.
The violation was classified as isolated in scope, meaning inspectors identified the problem in a limited number of cases rather than as a widespread pattern. The severity level, a D on the federal scale, indicates no actual harm was documented but that the potential for more than minimal harm existed. In the structure of federal nursing home enforcement, a D-level finding is the lowest tier that triggers a formal deficiency citation. It is the floor, not the ceiling.
What the inspection record does not contain is a plan of correction. Facilities cited for deficiencies are required to submit a response detailing how they will fix the problem and prevent it from happening again. Parsons Presbyterian Manor has not done that. The correction status listed in the inspection record is stark: deficient, provider has no plan of correction.
Psychotropic medications are among the most closely watched drugs in nursing home care, and for reasons that have accumulated over decades. The drugs include antipsychotics, antidepressants, anti-anxiety medications, and sedatives. In older adults, particularly those with dementia, these medications carry documented risks: falls, fractures, sedation, cognitive decline, and in some populations, increased risk of stroke and death. Federal regulators began pushing hard against their overuse in nursing homes years ago, and the concern has never gone away.
The problem that inspectors are trained to look for is not simply whether a resident is taking a psychotropic drug. It is whether the drug is appropriate, whether the dose is the lowest effective amount, whether the facility has tried other approaches first, and whether someone is actually monitoring what the drug is doing to the person taking it. When those questions don't have good answers, the drug stops being treatment and starts being management, a way of making a resident easier to care for rather than a way of helping them.
Parsons Presbyterian Manor is a long-term care facility operating in Parsons, a city of roughly 9,000 people in Labette County, near the Missouri and Oklahoma borders. The facility operates under the Presbyterian Manors of Mid-America network, a faith-based organization that runs senior living communities across Kansas and Missouri. The June 3 inspection was a standard health survey, the routine federal process that generates the deficiency records that appear on the CMS Care Compare website and inform the star ratings the public sees when researching nursing homes.
Four deficiencies came out of that inspection. The psychotropic medication finding was one of them.
The inspection narrative available in the public record is limited in detail. It identifies the regulatory tag, the category, the scope, the severity, and the correction status. It does not name the residents involved, describe the specific medications at issue, or quote the facility's staff. What it establishes, without ambiguity, is that inspectors found a problem serious enough to cite formally, that the problem involved psychotropic drugs being used in ways that may have functioned as restraints, and that the facility has not responded with a correction plan.
The absence of a correction plan is not a minor procedural gap. It is the mechanism by which facilities demonstrate to regulators that they understand what went wrong and have taken steps to fix it. Without it, there is no documented evidence that anything has changed for the residents whose care generated the citation in the first place.
Nursing home residents who receive unnecessary psychotropic medications often cannot advocate for themselves. Many have dementia. Many have limited ability to communicate that they feel sedated, confused, or different than they did before a medication was added or increased. Family members, if they are present and attentive, sometimes notice changes, a parent who seems more distant, less responsive, harder to reach in conversation. But they often don't know what medications have been added or why, and facilities are not always forthcoming.
The federal deficiency system exists, in part, because that information asymmetry is built into the situation. Residents and families frequently don't know what they don't know. Inspectors go in, review records, observe residents, interview staff, and produce findings that become public. The citation at Parsons Presbyterian Manor is now part of that public record.
What it doesn't tell us is what happens next. The facility has offered no correction plan. There is no documented commitment to review the medications of affected residents, to retrain staff, to change prescribing practices, or to ensure that the psychotropic drugs being administered in that building are actually serving the people taking them.
The regulatory tag at the center of this citation, F0605, sits within the broader framework of protections against abuse, neglect, and exploitation. The placement is intentional. Federal regulators have long held that chemical restraint, the use of medication to subdue or limit a resident rather than to treat a medical condition, is a form of harm. Not a billing error. Not a paperwork problem. Harm.
The severity classification in this case says no actual harm was documented. That finding reflects what inspectors could establish from the records and observations available to them during the survey. It does not mean the residents involved experienced no effects from the medications in question. It means inspectors did not document harm at the level required to push the severity rating higher.
The distinction is meaningful in regulatory terms. It is less meaningful to a resident who is sitting in a chair in a Kansas nursing home, more sedated than they need to be, because no one has taken a close enough look at what they're taking and why.
Parsons Presbyterian Manor has not explained, at least not in any record available to the public, what it intends to do about that.
Full Inspection Report
The details above represent a summary of key findings. View the complete inspection report for Parsons Presbyterian Manor from 2026-06-03 including all violations, facility responses, and corrective action plans.
Additional Resources
Data source: Official federal inspection data from the Centers for Medicare & Medicaid Services (CMS).
Editorial process: AI-synthesized regulatory data, reviewed for accuracy by our editorial team.
Professional review: All content reviewed by Christopher F. Nesbitt, Sr., NH EMT & BU-trained Paralegal.
Last verified: August 4, 2026 · Our methodology
PARSONS PRESBYTERIAN MANOR in PARSONS, KS was cited for violations during a health inspection on June 3, 2026.
The June 2026 inspection of Parsons Presbyterian Manor produced four deficiency citations.
Health inspections identify deficiencies that facilities must correct. Violations range from minor documentation issues to serious safety concerns. Review the full report below for specific details and facility response.